• PO Box 450 Mawson ACT, 2607 Australia

  • 02 6260 4022

Tech Alert: TGA Pharmacovigilance FAQs; Safety advisory Eucommia ulmoides

01 Feb 2021 11:58 AM | Anonymous member (Administrator)

Today's technical alert contains:

- Important contextual information for members on the TGA's recently published pharmacovigilance 'FAQs', including further details of sponsor pharmacovigilance obligations; and

 - Information on the TGA issued safety advisory for Eucommia ulmoides in response to one reported allergic reaction to a product containing Eucommia.

Copyright © 2019 Complementary Medicines Australia. All rights reserved.

Powered by Wild Apricot Membership Software